197 results on '"Hudson, Barry I."'
Search Results
2. RAGE inhibition to decrease cancer therapy related cardiotoxicity in women with early breast cancer (RAGE).
3. Comment on “The lingering mysteries of metastatic recurrence in breast cancer”
4. Relationships Between Serum Cortisol, RAGE-Associated s100A8/A9 Levels, and Self-Reported Cancer-Related Distress in Women With Nonmetastatic Breast Cancer
5. A low-glucose eating pattern is associated with improvements in glycemic variability among women at risk for postmenopausal breast cancer: an exploratory analysis
6. Associations of hyperglycemia and insulin resistance with biomarkers of endothelial dysfunction in Hispanic/Latino youths: Results from the Hispanic Community Children's Health Study/Study of Latino Youth (SOL Youth)
7. Regulation of Receptor for Advanced Glycation End Products (RAGE) Ectodomain Shedding and Its Role in Cell Function
8. Supplementary Table 1 from Alternatively Spliced RAGEv1 Inhibits Tumorigenesis through Suppression of JNK Signaling
9. Supplementary Figure 2 from Alternatively Spliced RAGEv1 Inhibits Tumorigenesis through Suppression of JNK Signaling
10. Supplementary Figure 1 from Alternatively Spliced RAGEv1 Inhibits Tumorigenesis through Suppression of JNK Signaling
11. Data from Alternatively Spliced RAGEv1 Inhibits Tumorigenesis through Suppression of JNK Signaling
12. Supplementary Methods, Legends for Table 1, Figures 1-3 from Alternatively Spliced RAGEv1 Inhibits Tumorigenesis through Suppression of JNK Signaling
13. Supplementary Figure 3 from Alternatively Spliced RAGEv1 Inhibits Tumorigenesis through Suppression of JNK Signaling
14. Abstract P4-08-10: Azeliragon (TTP488), an orally- available small molecule RAGE inhibitor, reduces metastasis in preclinical mouse models of breast cancer
15. Abstract B46: Immune characterization of C57BL/6J syngeneic breast cancer mouse models for application in immunotherapy development
16. High-density lipoprotein subfractions and carotid plaque: The Northern Manhattan Study
17. Serum levels of soluble receptor for advanced glycation end-products and metabolic syndrome: The Northern Manhattan Study
18. The Aspirin Conundrum—Navigating Negative Results, Age, Aging Dynamics, and Equity.
19. Comment on “The lingering mysteries of metastatic recurrence in breast cancer”
20. RAGE binds C1q and enhances C1q-mediated phagocytosis
21. Association of serum soluble Receptor for Advanced Glycation End-products with subclinical cerebrovascular disease: The Northern Manhattan Study (NOMAS)
22. Subfractions of High-Density Lipoprotein-Cholesterol and Carotid Intima-Media Thickness: The Northern Manhattan Study
23. Receptor for advanced glycation endproducts mediates pro-atherogenic responses to periodontal infection in vascular endothelial cells
24. Glycation and diabetes: The RAGE connection
25. Interaction of the RAGE Cytoplasmic Domain with Diaphanous-1 Is Required for Ligand-stimulated Cellular Migration through Activation of Rac1 and Cdc42
26. Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice
27. The ligand/RAGE axis: Lighting the fuse and igniting vascular stress
28. RAGE: A Novel Target for Drug Intervention in Diabetic Vascular Disease
29. Soluble receptor for advanced glycation end products: a new biomarker in diagnosis and prognosis of chronic inflammatory diseases
30. The RAGE Gly82Ser polymorphism is not associated with cardiovascular disease in the Framingham offspring study
31. Receptor for Advanced Glycation End Products and Its Ligands: A Journey from the Complications of Diabetes to Its Pathogenesis
32. Glucose, Glycation, and RAGE: Implications for Amplification of Cellular Dysfunction in Diabetic Nephropathy
33. The Functional −374 T/A RAGE Gene Polymorphism Is Associated With Proteinuria and Cardiovascular Disease in Type 1 Diabetic Patients
34. The functional--374 T/A RAGE gene polymorphism is associated with proteinuria and cardiovascular disease in type 1 diabetic patients. (Brief Genetics Report)
35. Characterization of Allelic and Nucleotide Variation Between the RAGE Gene on Chromosome 6 and a Homologous Pseudogene Sequence to Its 5′ Regulatory Region on Chromosome 3: Implications for Polymorphic Studies in Diabetes
36. Study of the −429 T/C and −374 T/A Receptor For Advanced Glycation End Products Promoter Polymorphisms in Diabetic and Nondiabetic Subjects With Macrovascular Disease
37. Effects of Novel Polymorphisms in the RAGE Gene on Transcriptional Regulation and Their Association With Diabetic Retinopathy
38. Blockade of receptor for advanced glycation endproducts: a new target for therapeutic intervention in diabetic complications and inflammatory disorders
39. Abstract P3-01-11: Targeting RAGE inhibits breast cancer invasion and metastasis
40. Abstract LB-328: Loss of TFF1 leads to activation of RAGE in mouse and human gastric tumorigenesis
41. 852 – Overexpression of Rage and Its Ligands is Mediated by Tff1 Loss in Mouse and Human Gastric Tumorigenesis
42. The effects of a randomized trial of brief forms of stress management on RAGE‐associated S100A8/A9 in patients with breast cancer undergoing primary treatment
43. Serum soluble RAGE levels and carotid atherosclerosis: The Northern Manhattan Study (NOMAS)
44. Targeting RAGE Signaling in Inflammatory Disease
45. Abstract MP42: Subfractions of High-density Lipoprotein Cholesterol and Carotid Intima-media Thickness
46. Soluble RAGE: a hot new biomarker for the hot joint?
47. Fibroblast Growth Factor 23 Is Associated With Carotid Plaque Presence and Area
48. Abstract 2270: RAGE-ligand signaling drives breast cancer invasion and metastasis
49. Alternative Splicing of the RAGE Cytoplasmic Domain Regulates Cell Signaling and Function
50. Abstract 247: Association of Soluble RAGE Levels with Carotid Atherosclerosis: The Northern Manhattan Study (NOMAS)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.